• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


Price not available for EVOTF:US

Snapshot for Evotec AG (EVOTF)

Open: - Day's Range: - Volume: 0
Previous Close: 3.8000 52wk Range: 3.8000 - 5.9800 1-Yr Rtn: -

Stock Chart for EVOTF

No chart data available.
  • EVOTF:US 3.8000
  • 1M
  • 1Y
Interactive EVOTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVOTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.0190
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 131.71
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVOTF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for EVOTF

Evotec AG offers drug research, development, and manufacturing services. The Company offers assay development and screening and compound optimization services to pharmaceutical companies. Evotec also develops drugs on its own for out-licensing.

Werner LanthalerChief Executive OfficerColin BondCFO/Member-Mgmt Board
Mario PolywkaCOO/Member-Mgmt BdCord E DohrmannChief Scientific Officer
More Company Profile & Key Executives for EVOTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil